NEAT1 promotes cell proliferation in multiple myeloma by activating PI3K/AKT pathway

被引:0
作者
Xu, H. [1 ]
Li, J. [1 ]
Zhou, Z. -G. [1 ]
机构
[1] Jiangsu Univ, Dept Hematol, Affiliated Yixing Hosp, Yixing, Peoples R China
关键词
NEAT1; PI3K/AKT pathway; Cell proliferation; Multiple myeloma; NONCODING RNA; STEM-CELLS; CANCER; PATHOGENESIS; LEUKEMIA;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: The role of long-chain non-coding NEAT1 (Nuclear enriched abundant transcripts) in multiple myeloma (MM) and its underlying mechanisms were investigated. PATIENTS AND METHODS: The expression of NEAT1 and SOX13 was detected in CD138+ positive cells collected from MM and healthy subjects. Meanwhile, the relationship between NEAT1 level and the prognosis as well as clinical staging was analyzed. Virus transfection method was used to change the expression of NEAT1 and SOX13 in tumor cells. and then the effect of NEAT1 on cell proliferation, apoptosis and cell cycle was examined. The influence of NEAT1 on the regulation of SOX13 was explored through recovery experiments and Western blot. In addition. the regulation effect of NEAT1 on tumor formation was explored in vivo. RESULTS: NEAT1 and SOX13 were highly expressed in MM patients and MM cell lines, and the patient survival rate and platelet count were significantly decreased in the highly expressed NEAT1 group. Low expression of NEAT1 could inhibit the PI3K/AKT pathway to suppress cell proliferation, promote apoptosis, and inhibit cell cycle. Overexpression of SOX13 was able to partially restore the inhibitory effect of NEAT1 on cell proliferation. Meanwhile, it was found that low expression of NEAT1 significantly inhibited tumor formation in vivo. CONCLUSIONS: Highly expressed NEAT1 promoted cell proliferation through activation of PI3K/AKT pathway, thus participating in the development of MM.
引用
收藏
页码:6403 / 6411
页数:9
相关论文
共 22 条
[1]   Pathogenesis of Myeloma [J].
Anderson, Kenneth C. ;
Carrasco, Ruben D. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6, 2011, 6 :249-274
[2]   Long noncoding RNAs in cancer: mechanisms of action and technological advancements [J].
Bartonicek, Nenad ;
Maag, Jesper L. V. ;
Dinger, Marcel E. .
MOLECULAR CANCER, 2016, 15
[3]   Pathogenesis beyond the cancer clone(s) in multiple myeloma [J].
Bianchi, Giada ;
Munshi, Nikhil C. .
BLOOD, 2015, 125 (20) :3049-3058
[4]   p53-dependent non-coding RNA networks in chronic lymphocytic leukemia [J].
Blume, C. J. ;
Hotz-Wagenblatt, A. ;
Huellein, J. ;
Sellner, L. ;
Jethwa, A. ;
Stolz, T. ;
Slabicki, M. ;
Lee, K. ;
Sharathchandra, A. ;
Benner, A. ;
Dietrich, S. ;
Oakes, C. C. ;
Dreger, P. ;
te Raa, D. ;
Kater, A. P. ;
Jauch, A. ;
Merkel, O. ;
Oren, M. ;
Hielscher, T. ;
Zenz, T. .
LEUKEMIA, 2015, 29 (10) :2015-2023
[5]   Altered Nuclear Retention of mRNAs Containing Inverted Repeats in Human Embryonic Stem Cells: Functional Role of a Nuclear Noncoding RNA [J].
Chen, Ling-Ling ;
Carmichael, Gordon G. .
MOLECULAR CELL, 2009, 35 (04) :467-478
[6]   Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients [J].
Ding, Chaofeng ;
Yang, Zhe ;
Lv, Zhen ;
Du, Chengli ;
Xiao, Heng ;
Peng, Chuanhui ;
Cheng, Shaobing ;
Xie, Haiyang ;
Zhou, Lin ;
Wu, Jian ;
Zheng, Shusen .
ONCOLOGY LETTERS, 2015, 9 (02) :955-963
[7]  
Girnius S, 2013, Leuk Suppl, V2, pS3, DOI 10.1038/leusup.2013.2
[8]  
Guo S, 2015, INT J CLIN EXP PATHO, V8, P5395
[9]   The emerging role of IncRNAs in cancer [J].
Huarte, Maite .
NATURE MEDICINE, 2015, 21 (11) :1253-1261
[10]  
Ju AH, 2017, J BUON, V22, P1471